Demonstrates that noncatechin flavonoid extract reduces diabetes complications in SHR rats, suggesting potential therapeutic uses.
Objectives This study examined the effects of the noncatechin flavonoids (NCFs), a mixture of a range of flavonoids obtained from Camellia sinensis (L.) Kuntze seeds on Type 2 diabetes mellitus (T2DM). Methods Thirty-two 10-week-old SHR rats were randomly assigned to four groups. The RD group was fed a regular diet. The DM group was injected with ‘streptozotocin (STZ, 50 mg/kg)’ and nicotinamide ‘(NA, 100 mg/kg)’ and fed a high-fat diet (HFD). The NCF0.5 group or NCF5 group was injected with ‘STZ/NA’ and fed HFD plus oral gavage NCF 0.5 or 5 mg/kg/day for four weeks, respectively. Key findings T2DM was successfully induced as evidenced by lower body weight and higher blood pressure, blood glucose, HbA1c; lower insulin, GLP-1; and higher IL-6, TNF-α, and MDA and deterioration of proteins regulating vasocontraction and vasodilation (AGTR1, AGTR2, ETB, eNOS), regulating glucose metabolism (AMPK, IRB, IRS-1, PI3K, Akt/PKB, PPAR-γ, GLUT-4, HKase, PKase, GSK-3α, PEPCK, G6Pase) and free radical scavengers (catalase, GPx). These biochemical parameters were improved dose dependently by NCFs, suggesting that association with NCFs had anti-T2DM, antiperoxidation, and anti-inflammatory effects. Conclusions NCFs possessing total flavonoids (42.5 ± 3.4 μg/mg), not saponins and catechins, could efficiently control T2DM. Thus, NCF could potentially develop into an agent for controlling T2DM and related complications.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: